849805-25-0

Basic information

• Product Name: Methyl 2-amino-6-chloronicotinate
• Synonyms: Methyl 2-amino-6-chloronicotinate;Methyl 2-amino-6-chloroni...;methyl 2-amino-6-chloropyridine-3-carboxylate;2-Amino-6-chloro-nicotinic acid methyl ester
• CAS NO: 849805-25-0
• Molecular Formula: C₇H₇ClN₂O₂
• Molecular Weight: 186.59568
• Mol File: 849805-25-0.mol
• Article Data: 20

Chemical Properties

• Boiling Point: 289.2±35.0 °C(Predicted)
• Appearance: /
• Density: 1.384±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 0.61±0.50(Predicted)
• CAS DataBase Reference: Methyl 2-amino-6-chloronicotinate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-amino-6-chloronicotinate(849805-25-0)
• EPA Substance Registry System: Methyl 2-amino-6-chloronicotinate(849805-25-0)

Safety Data

• Hazardous Substances Data: 849805-25-0(Hazardous Substances Data)

Usage

General Description

Methyl 2-amino-6-chloronicotinate is an organic compound that belongs to the family of Pyridines and Derivatives. It's a chemical intermediate used in the synthesis of active pharmaceutical ingredients (APIs). Its molecular formula is C7H7ClN2O2 and typically appears as a light yellow, almost clear liquid or solid. Special handling and personal protection are required during its use due to its potential health hazards. It is not a common substance and is primarily used in scientific or industrial settings.

InChI:InChI=1S/C7H7ClN2O2/c1-12-7(11)4-2-3-5(8)10-6(4)9/h2-3H,1H3,(H2,9,10)

Upstream product

• 67-56-1 methanol 
• 58584-92-2 2-amino-6-chloronicotinic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 1356353-33-7 methyl 6-chloro-2-[(4-methoxybenzyl)amino]pyridine-3-carboxylate 
• 74-88-4 methyl iodide 
• 38496-18-3 2,6-dichloropyridine-3-carboxylic acid 
• 65515-28-8 methyl 2,6-dichloronicotinate 

Downstream Products

• 1312697-84-9 5-[5-(3,5-bistrifluoromethylphenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-imidazo[1,2-a]pyridine-8-carboxylic acid 
• 1312697-70-3 2-amino-6-[5-(3,5-bistrifluoromethyl-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-nicotinic acid methyl ester 
• 1312697-71-4 5-[5-(3,5-bistrifluoromethylphenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-imidazo[1,2-a]pyridine-8-carboxylic acid methyl ester 
• 1312697-69-0 6-[5-(3,5-bistrifluoromethyl-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-bis(tert-butoxycarbonyl)amino-nicotinic acid methyl ester 
• 1391062-87-5 2-amino-6-chloronicotinic acid N-oxide 
• 1356352-86-7 2-[(4,4-difluorocyclohexyl)oxy]-3-[4-(2,2,2-trifluoroethoxy)phenyl]pyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione 
• 1356352-87-8 2-(2,2-difluoroethoxy)-3-[4-(2,2,2-trifluoroethoxy)phenyl]pyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione 
• 1356352-91-4 2-methoxy-3-[4-(2,2,2-trifluoroethoxy)phenyl]pyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione 
• 1356352-95-8 2-(1-methylethoxy)-3-[4-(2,2,2-trifluoroethoxy)phenyl]pyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione 
• 1356353-51-9 7-[(4-methoxybenzyl)amino]-2-thioxo-3-[4-(2,2,2-trifluoroethoxy)phenyl]-2,3-dihydropyrido[2,3-d]pyrimidin-4(1H)-one 
• 1356353-52-0 2-(ethylsulfanyl)-7-[(4-methoxybenzyl)amino]-3-[4-(2,2,2-trifluoroethoxy)phenyl]pyrido[2,3-d]pyrimidin-4(3H)-one 
• 1356353-06-4 7-amino-2-(ethylsulfanyl)-3-[4-(2,2,2-trifluoroethoxy)phenyl]pyrido[2,3-d]pyrimidin-4(3H)-one 
• 1356352-54-9 2-(ethylsulfanyl)-7-methoxy-3-[4-(2,2,2-trifluoroethoxy)phenyl]pyrido[2,3-d]pyrimidin-4(3H)-one 
• 1356352-57-2 7-methoxy-2-(methylsulfanyl)-3-[4-(2,2,2-trifluoroethoxy)phenyl]pyrido[2,3-d]pyrimidin-4(3H)-one 

Relevant articles and documents

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula (I).

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF

The present invention provides a compound useful for the prophylaxis or treatment of eicosanoid-associated diseases such as atherosclerosis, atherothrombosis, diabetes, obesity, asthma, fever, pain, cancer, rheumatism, osteoarthritis, atopic dermatitis and the like, and having superior pharmacological action, physicochemical properties and the like. The present invention relates to a compound represented by the following formula: wherein each symbol is as defined in the specification, or a salt thereof.